Abstract:Osteoporosis is a metabolic skeletal disorder in which bone mass is depleted and bone structure is destroyed to the degree that bone becomes fragile and prone to fractures. Emerging evidence suggests that N6-methyladenosine (m6A) modification, a novel epitranscriptomic marker, has a significant role in bone development and metabolism. M6A modification not only participates in bone development, but also plays important roles as writers and erasers in the osteoporosis. M6A methyltransferase METTL3 and demethyltransferase FTO involves in the delicate process between adipogenesis differentiation and osteogenic differentiation, which is important for the pathological development of osteoporosis. Conditional knockdown of the METTL3 in bone marrow stem cells (BMSCs) could suppress PI3K-Akt signaling, limit the expression of bone formation-related genes (such as Runx2 and Osterix), restrain the expression of vascular endothelial growth factor (VEGF) and down-regulate the decreased translation efficiency of parathyroid hormone receptor-1 mRNA. Meanwhile, knockdown of the METTL3 significantly promoted the adipogenesis process and janus kinase 1 (JAK1) protein expression via an m6A-dependent way. Specifically, there was a negative correlation between METTL3 expression and porcine BMSCs adipogenesis. The evidence above suggested that the relationship between METTL3 expression and adipogenesis was inverse, and osteogenesis was positive, respectively. Similarly, FTO regulated for BMSCs fate determination during osteoporosis through the GDF11-FTO-PPARγ axis, prompting the shift of MSC lineage commitment to adipocyte and inhibiting bone formation during osteoporosis. In this systematic review, we summarize the most up-to-date evidence of m6A RNA modification in osteoporosis and highlight the potential role of m6A in prevention, treatment, and management of osteoporosis.

m6A demethylase FTO and osteoporosis: potential therapeutic interventions

The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG

RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation

Regulatory Role of RNA N6-Methyladenosine Modification in Bone Biology and Osteoporosis

FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

Effect of demethyltransferase FTO on tumor progression

Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders

N6-methyladenosine Demethyltransferase FTO Mediated M6a Modification of Estrogen Receptor Alpha in Non-Small Cell Lung Cancer Tumorigenesis

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

N 6 -methyladenosine demethyltransferase FTO mediated m 6 A modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis

FTO in oral diseases: Functions, mechanisms, and therapeutic potential

FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis

RNA N6‐methyladenosine demethylase FTO inhibits glucocorticoid‐induced osteoblast differentiation and function in bone marrow mesenchymal stem cells

Recent Advances of M6a Demethylases Inhibitors and Their Biological Functions in Human Diseases

The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging

The Role of M6a in Osteoporosis and the Differentiation of Mesenchymal Stem Cells into Osteoblasts and Adipocytes

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

FTO-mediated m6A demethylation of pri-miR-3591 alleviates osteoarthritis progression

A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities

The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers